Pfister, K., Friedl, T. W. P., Hartkopf, A., Mergel, F., Huesmann, S., Mehmeti, F., Schäffler, H., Fink, A., Braun, T., Heublein, S., Wiesmüller, L., Pantel, K., Rack, B., Fasching, P. A., Janni, W. (2025). Study Protocol of SURVIVE HERoes (NCT06643585): Trastuzumab Deruxtecan for molecular relapse in HER2+/ Low early breast cancer with ctDNA positivity after primary therapy. PLoS ONE. https://doi.org/10.1371/journal.pone.0322156